Dubai Health Authority Circular No. CIR-2021-00000059
Recall, Lifting Suspension and Safety updates of a Pharmaceutical Product
To all health, care facilities and all health care practitioners in Dubai's private health sector
Referring to the above subject, DHA would like to notify all health care facilities and practitioners regarding the Circular issued by MOHAP for information and adherance to what is stated
Voluntary recall to remove specific lots Footprint Ultra PK Suture Anchor
Medical Device field safety action Implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds)
Recall and suspension of registration for pharmaceutical product LORINASE TABLETS
False Positive Results with Roche Molecular Systems, Inc. Cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the Cobas® Liat® System
Voluntary recall four lots of medical product Acyclovir Sodium Injection, 50 mg/ml
Medical Device field safety notice Disposable cuffs for tourniquet application
Lifting the suspension on the registrations & marketing of the product Julmentin Forte 312mg/5ml oral suspension
Lamictal (lamotrigine): drug safety communication Lamitor, Lamictal, Lamogin
Medical Device alert Roche Diabetes mySugr Bolus Calculator App
Medical Device field safety notice Valiant Navion Thoracic Stent Graft System
Medical Device field safety notice Subset of ASSURITY™ AND ENDURITY™ PACEMAKERS